Is adapalene 0.1% prescription-only in the EU?
Adapalene 0.1% (often marketed as topical adapalene gel) is generally regulated at the country level across the European Union, and prescription status can differ by member state. In practice, many EU markets treat topical adapalene 0.1% as a prescription product rather than an over-the-counter medicine, but you need the specific country to confirm the exact classification.
Why EU “prescription status” varies by country
The EU does not enforce one single, union-wide “prescription only” rule for every medicine. Each member state assigns the dispensing category (e.g., prescription-only vs non-prescription) under its national pricing and reimbursement and medicines classification systems. That’s why a product’s status can change when you move from, for example, France to Germany or Spain.
What to check to get the exact answer for your country
To confirm the prescription status for “adapalene 0.1%” in your specific EU country, look up:
- The product’s national medicines database entry (often lists “Rx only” / “prescription”).
- The specific marketing authorization (brand name + strength + dosage form, such as “gel 0.1%”).
- Local pharmacy guidance or patient information leaflets that state “By prescription.”
If you tell me the country, I can narrow it down
If you share which EU country you mean (and ideally the brand name, e.g., Differin or a local equivalent), I can give a precise prescription-status answer for that market.